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Background: MicroRNA-92a is a small noncoding RNA that has been shown to regulate angiogenesis. We investigated whether controlled release 
of antagomir designed to inhibit microRNA-92a promotes angiogenesis and cardiomyogenesis after myocardial infarction (MI) in rats.
Methods: MI was created by ligation of the left coronary artery in rats. Gelatin hydrogel microspheres-incorporated patch impregnated with 
antagomir-92a was placed on the surface of the infarct area of the left ventricle (LV) at the time of MI. Cardiac geometry and function was assessed 
by echocardiography. Myocardial fibrosis was evaluated by Masson Trichrome staining. Angiogenesis was assessed by the density of CD31-positive 
capillaries and the number of _-smooth muscle actin-positive vessels. To identify proliferating cardiomyocytes, BrdU was co-impregnated with 
antagomir-92a, and cardiomyocytes were stained with _-actinin. Intra-bone marrow-bone marrow transplantation (IBM-BMT) from the transgenic 
rats expressing green fluorescence protein was performed to track the bone marrow-derived cells.
Results: There was no difference in LV wall motion between rats with the antagomir-92a patch and the patch alone 1 hour after MI. However, 
myocardial thinning was inhibited, and LV wall motion was improved 3 days after MI in rats with the antagomir-92a patch. Myocardial fibrosis in 
the infarct area was significantly reduced by the antagomir-92a patch 14 days after MI (31±3 % vs 15±2 % LV area). The number of capillaries 
and small vessels within the infarct area was increased by the antagomir-92a patch associated with an increase in the number of proliferating 
cardiomyocytes. The patch alone or the patch impregnated with antagomir-Co had no effect on LV wall motion, myocardial fibrosis, angiogenesis and 
cardiomyogenesis after MI. There were no endothelial cells and cardiomyocytes derived from bone marrow cells in the infarcted myocardium with the 
antagomir-92a patch.
Conclusions: Controlled release of antagomir-92a using gelatin hydrogel microspheres-incorporated patch enhances angiogenesis and 
cardiomyogenesis originated from non-bone marrow cells and improves cardiac function and remodeling after MI.
